Skip to main content
  • Long-term outcomes of drug-eluting stents versus bare metal stents in saphenous vein graft interventions. Evidence from a meta-analysis of randomized controlled trials

    Highlights

    • DES results in similar outcomes as BMS in SVG PCI up to 42 months of mean follow up.
    • SVG PCI results in excess of 32% major adverse cardiovascular outcomes at 42 months.
    • Post CABG patients who undergo SVG PCI have a mortality rate of 15% at 42 months.

    Abstract

    Background

    The optimal stent for use in saphenous vein graft (SVG) intervention is still debatable. Multiple randomized trials have compared drug-eluting stents (DES) to bare metal stents (BMS) in SVG interventions with conflicting results.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details